Intrinsic Value
CROSS COUNTRY HEALTHCARE INC · CCRN
Conservative
More adverse but historically defensible assumptions.
$3.75
Base
The model's central intrinsic-value estimate.
$2.51
Optimistic
More favorable but historically defensible assumptions.
$4.88
Scenarios are the same model run under different but historically defensible assumptions. They are not price targets. Where a valuation gap is shown it is a comparison with a recent close, not a forecast return; where the price is stale, no gap is shown at all.
Model confidence: 74%Valuation as of Sep 21, 2026Latest filing used Mar 9, 2026
Confidence reflects data completeness, accounting quality, and model reliability. It is not a probability of future price.
Valuation drivers
- Normalized ROE
- 1.1%
- Cost of equity
- 10.24%
- Terminal ROE
- 5.7%
- Terminal growth
- 2.50%
- Book common equity
- $322.8M
- Intrinsic common equity
- $81.4M
- Terminal-value share
- -103.4%
Model notes (11)
- Intrinsic value is below book; the forecast return does not cover the cost of equity (Base case)
- Terminal value is -103% of intrinsic equity value (Base case)
- Forecast payout capped at 100% of earnings left the demonstrated range (Conservative case)
- Intrinsic value is below book; the forecast return does not cover the cost of equity (Conservative case)
- Book-value rollforward residual of 20.4%(FY2017)
- Intrinsic value is below book; the forecast return does not cover the cost of equity (Optimistic case)
- Combined ratio unavailable — partial insurance expense coverage
- Terminal return on equity is below the cost of equity; terminal value is negative
- Year 1 forecast net income negative payout suspended
- Year 2 forecast net income negative payout suspended
- Year 3 forecast net income negative payout suspended
Model details
- Normalization
- V1
- Scenario
- V2
- Confidence
- V1
- Engine version
- valuation-1.0.1-share-units-terminal
- Data snapshot
- filed:2026-03-09